Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma. [electronic resource]
Producer: 19990610Description: 305-12 p. digitalISSN:- 1042-8194
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carmustine -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Drug Resistance, Multiple
- Etoposide
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Leukocyte Count -- drug effects
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Neoplasm Staging
- Recurrence
- Survival Analysis
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.